Skip to content

News Archive

The Partnership for Safe Medicines has been publishing information about the counterfeit drug problem around the world for more than a decade. With experts leading the organization and a committed and passionate set of writers and editors, our content is more in-depth than many other sources, which simply copy links to the news from other websites.

FDA Alert: Med Man Expands Voluntary Nationwide Recall of Up2 and Bow & Arrow Due to Presence of Undeclared Sildenafil

February 24, 2020

This is a reprint of an FDA Alert. When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the company. Company Announcement Date: February 24, 2020 FDA Publish Date: February 24, 2020 Product Type: Dietary Supplements…

FDA Worked With Indian Government To Seize 500 Counterfeit Drug Shipments in January

February 21, 2020

The U.S. Food and Drug Administration (FDA) has just announced a successful joint operation with the Government of India targeting counterfeit prescription drugs, counterfeit over-the-counter medications, fake medical devices, and misbranded dietary supplements containing harmful ingredients. 

A bottle of poison pills casts a shadow over a map of the U.S.

PSM files comments on HHS’s proposed Canadian drug importation rules; cites danger to patients

February 11, 2020

Today The Partnership for Safe Medicines filed comments with Health and Human Services about the dangers posed by its draft regulations for state-based Canadian drug importation programs. PSM cited historic problems with and patient harm from Canadian vendors selling counterfeit medications to U.S. patients and medical practices; showed broad opposition to the plan by Canadian stakeholders; and provides alternatives that don’t impact patient safety.

Counterfeit Medicines Are a Problem in the European Union—A Problem that is Continuing to Grow

February 9, 2020

According to a report from Europol’s Intellectual Property Crime Threat Assessment 2019, “Counterfeit pharmaceuticals pose a growing threat to the EU, affecting a large number of Member States. A wide and increasingly diverse range of medicines is targeted by counterfeiters.”
The Europol ICP Threat Assessment reports that there has been an increase in seizures of counterfeit drugs used in the treatment of serious illnesses, as well as a growing number of counterfeit drug incidents affecting the legal drug supply chain. 

Security Breach Illustrates Another Danger of Fake Online Pharmacies

January 30, 2020

Planet Drugs Direct, an online pharmacy based in Winnipeg, Canada, has announced a data breach. Hackers broke into their servers, exposing customers’ names, medical details, and contact and banking information. Legitscript is unequivocal in calling Planet Drugs Direct a “Rogue Internet Pharmacy,” their worst rating for online pharmacies, accusing them of violating state and federal laws.

Infographic: Counterfeiting By The Numbers

January 30, 2020

Our infographic, “Counterfeiting by the Numbers,” highlights facts from the U.S. Department of Homeland Security’s January 2020 report, Combating Trafficking in Counterfeit and Pirated Goods, which documents the extraordinary scale of the global counterfeiting market and its effects across all economic sectors—including medicines.

PSM Statement on the passage of S.3201, which extends the DEA’s temporary scheduling of fentanyl-related substances as Schedule I for 15 months.

January 29, 2020

The Partnership for Safe Medicines (PSM) stands with our law enforcement partners in commending the U.S. Senate and the U.S. House of Representatives for their swift passage of S.3201, which would extend the DEA’s temporary scheduling of fentanyl-related substances to be Schedule I controlled substances for an additional 15 months. Without this reauthorization, criminals could…

New Jersey Enacts Increased Penalties for Counterfeit Drug Crimes

January 21, 2020

The Governor of New Jersey has just signed A-5037, a new law designed to increase penalties for counterfeit drug crimes committed in the state.

Counterfeiter Who Made At Least 4.3 Million Fake Xanax Pills Sentenced

January 17, 2020

The U.S. Department of Justice announced that Stephan Caamano, who manufactured and sold at least 4.3 million counterfeit Xanax pills, will spend the next 13 years in federal prison after pleading guilty to his crimes…

Canadian health law experts predict: Canada won’t end up as the drugstore to the U.S.

January 16, 2020

This editorial by David C. Rosenbaum and Dara Jospé was published in the Financial Post on January 16, 2020. Rosenbaum is a partner of the law firm Fasken. Jospé is an associate for the same company.

Scroll To Top